Histological diversity in cholangiocellular carcinoma reflects the different cholangiocyte phenotypes

Hepatology

Volumn 55, Issue 6, 2012, Pages 1876-1888

  Komuta, Mina ^a   Govaere, Olivier ^a   Vandecaveye, Vincent ^a   Akiba, Jun ^b   Van Steenbergen, Werner ^a   Verslype, Chris ^a   Laleman, Wim ^a   Pirenne, Jacques ^a   Aerts, Raymond ^a   Yano, Hirohisa ^b   Nevens, Frederik ^a   Topal, Baki ^a   Roskams, Tania ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MUCIN;

ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; CANCER CELL CULTURE; CELL INVASION; CELL PROLIFERATION; FEMALE; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INTRAHEPATIC BILE DUCT; KLATSKIN TUMOR; LASER MICRODISSECTION; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; STEM CELL; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CALCIUM-BINDING PROTEINS; CHOLANGIOCARCINOMA; FEMALE; GENE EXPRESSION PROFILING; HUMANS; IMMUNOHISTOCHEMISTRY; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS;

EID: 84861534766     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.25595     Document Type: Article

References (31)

1. Desmet V, Roskams T, Vos RD. Normal anatomy. In: Feldman M, ed. Gastroenterology and Hepatology. The Comprehensive Visual Reference. Philadelphia, PA: Current Medicine, Inc.; 1997: 1.14.
2. Roskams TA, Theise ND, Balabaud C, Bhagat G, Bhathal PS, Bioulac-Sage P, et al. Nomenclature of the finer branches of the biliary tree: canals, ductules, and ductular reactions in human livers. HEPATOLOGY 2004; 39: 1739-1745.
3. Roskams T, Katoonizadeh A, Komuta M. Hepatic progenitor cells: an update. Clin Liver Dis 2010; 14: 705-718.
4. Komuta M, Spee B, Vander Borght S, De Vos R, Verslype C, Aerts R, et al. Clinicopathological study on cholangiolocellular carcinoma suggesting hepatic progenitor cell origin. HEPATOLOGY 2008; 47: 1544-1556.
5. Nakanuma Y, Curado M-P, Franceschi S, Gores G, Paradis V, Sripa B, et al. Intrahepatic cholangiocarcinoma. Lyon, France: IARC; 2010.
6. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti IIIA. Perihilar Bile Ducts. 7th ed. Chicago, IL: Springer; 2010.
7. Han JK, Choi BI, Kim AY, An SK, Lee JW, Kim TK, et al. Cholangiocarcinoma: pictorial essay of CT and cholangiographic findings. Radiographics 2002; 22: 173-187.
8. Liver Cancer Study Group of Japan. Classification of Primary Liver Cancer. 1st English ed. Tokyo, Japan: Kanehara; 1997.
9. Levy M, Lin F, Xu H, Dhall D, Spaulding BO, Wang HL. S100P, von Hippel-Lindau gene product, and IMP3 serve as a useful immunohistochemical panel in the diagnosis of adenocarcinoma on endoscopic bile duct biopsy. Hum Pathol 2010; 41: 1210-1219.
10. Roskams T, De Vos R, Van Eyken P, Myazaki H, Van Damme B, Desmet V. Hepatic OV-6 expression in human liver disease and rat experiments: evidence for hepatic progenitor cells in man. J Hepatol 1998; 29: 455-463.
11. Okabe M, Tsukahara Y, Tanaka M, Suzuki K, Saito S, Kamiya Y, et al. Potential hepatic stem cells reside in EpCAM+ cells of normal and injured mouse liver. Development 2009; 136: 1951-1960.
12. Schmelzer E, Zhang L, Bruce A, Wauthier E, Ludlow J, Yao HL, et al. Human hepatic stem cells from fetal and postnatal donors. J Exp Med 2007; 204: 1973-1987.
13. Jozefczuk J, Stachelscheid H, Chavez L, Herwig R, Lehrach H, Zeilinger K, et al. Molecular characterization of cultured adult human liver progenitor cells. Tissue Eng Part C Methods 2010; 16: 821-834.
14. Fong D, Moser P, Krammel C, Gostner JM, Margreiter R, Mitterer M, et al. High expression of TROP2 correlates with poor prognosis in pancreatic cancer. Br J Cancer 2008; 99: 1290-1295.
15. Iemura A, Maruiwa M, Yano H, Kojiro M. A new human cholangiocellular carcinoma cell line (KMC-1). J Hepatol 1992; 15: 288-298.
16. Murakami T, Yano H, Maruiwa M, Sugihara S, Kojiro M. Establishment and characterization of a human combined hepatocholangiocarcinoma cell line and its heterologous transplantation in nude mice. HEPATOLOGY 1987; 7: 551-556.
17. Yano H, Iemura A, Haramaki M, Momosaki S, Ogasawara S, Higaki K, et al. A human combined hepatocellular and cholangiocarcinoma cell line (KMCH-2) that shows the features of hepatocellular carcinoma or cholangiocarcinoma under different growth conditions. J Hepatol 1996; 24: 413-422.
18. Theise ND, Yao JL, Harada K, Hytiroglou P, Portmann B, Thung SN, et al. Hepatic 'stem cell' malignancies in adults: four cases. Histopathology 2003; 43: 263-271.
19. Kim H, Park C, Han KH, Choi J, Kim YB, Kim JK, et al. Primary liver carcinoma of intermediate (hepatocyte-cholangiocyte) phenotype. J Hepatol 2004; 40: 298-304.
20. Roskams T. Anatomic pathology of hepatocellular carcinoma: impact on prognosis and response to therapy 2011. Clin Liver Dis; 15: 245-259.
21. Roskams T. Liver stem cells and their implication in hepatocellular and cholangiocarcinoma. Oncogene 2006; 25: 3818-3822.
22. Donato R. S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. Int J Biochem Cell Biol 2001; 33: 637-668.
23. Hamada S, Satoh K, Hirota M, Kanno A, Ishida K, Umino J, et al. Calcium-binding protein S100P is a novel diagnostic marker of cholangiocarcinoma. Cancer Sci 2011; 102: 150-156.
24. Gutgemann I, Haas S, Berg JP, Zhou H, Buttner R, Fischer HP. CD56 expression aids in the differential diagnosis of cholangiocarcinomas and benign cholangiocellular lesions. Virchows Arch 2006; 448: 407-411.
25. Aishima S, Fujita N, Mano Y, Kubo Y, Tanaka Y, Taketomi A, et al. Different roles of S100P Overexpression in Intrahepatic Cholangiocarcinoma: Carcinogenesis of Perihilar Type and Aggressive Behavior of Peripheral Type. Am J Surg Pathol 2011; 35: 590-598.
26. Matsumura N, Yamamoto M, Aruga A, Takasaki K, Nakano M. Correlation between expression of MUC1 core protein and outcome after surgery in mass-forming intrahepatic cholangiocarcinoma. Cancer 2002; 94: 1770-1776.
27. Wang G, Platt-Higgins A, Carroll J, de Silva Rudland S, Winstanley J, Barraclough R, et al. Induction of metastasis by S100P in a rat mammary model and its association with poor survival of breast cancer patients. Cancer Res 2006; 66: 1199-1207.
28. van der Vegt B, de Roos MA, Peterse JL, Patriarca C, Hilkens J, de Bock GH, et al. The expression pattern of MUC1 (EMA) is related to tumour characteristics and clinical outcome of invasive ductal breast carcinoma. Histopathology 2007; 51: 322-335.
29. Muhlmann G, Spizzo G, Gostner J, Zitt M, Maier H, Moser P, et al. TROP2 expression as prognostic marker for gastric carcinoma. J Clin Pathol 2009; 62: 152-158.
30. Asayama Y, Tajima T, Okamoto D, Nishie A, Ishigami K, Ushijima Y, et al. Imaging of cholangiolocellular carcinoma of the liver. Eur J Radiol 2010; 75: e120-e125.
31. Rimola J, Forner A, Reig M, Vilana R, de Lope CR, Ayuso C, et al. Cholangiocarcinoma in cirrhosis: absence of contrast washout in delayed phases by magnetic resonance imaging avoids misdiagnosis of hepatocellular carcinoma. HEPATOLOGY 2009; 50: 791-798.